The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Occurrence of leukaemia following gene therapy of X-linked SCID
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“The text and reference should have been: See also Refs 14, 18 an”
BackgroundHIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,320
IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation
Lodolce, J. P., Boone, D. L., Chai, S., Swain, R. E., Dassopoulos, T., Trettin, S., & Ma, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80664-0 · Cited by 1,299
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Ferrando, A. A., Neuberg, D. S., Staunton, J., Loh, M. L., Huard, C., Raimondi, S. C., Behm, F. G., Pui, C.-H., Downing, J. R., Gilliland, D. G., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00018-1 · Cited by 1,131
Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-7 Receptor
Noguchi, M., Nakamura, Y., Russell, S. M., Ziegler, S. F., Tsang, M., Cao, X., & Leonard, W. J. (1993) · Science · doi:10.1126/science.8266077 · Cited by 1,109
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.-P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,058
Interleukin 15: biology and relevance to human disease
Fehniger, T. A., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.1.14 · Cited by 976
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., et al. (2002) · Science · doi:10.1126/science.1070104 · Cited by 975
Cytokine control of memory T-cell development and survival
Schluns, K. S., & Lefrançois, L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1052 · Cited by 882
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Sheai, J. J., et al. (1995) · Nature · doi:10.1038/377065a0 · Cited by 877
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 868
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
Puel, A., Ziegler, S. F., Buckley, R. H., & Leonard., W. J. (1998) · Nature Genetics · doi:10.1038/3877 · Cited by 813
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., et al. (1995) · Science · doi:10.1126/science.270.5237.797 · Cited by 803
New aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752
Sharing of the Interleukin-2 (IL-2) Receptor γ Chain Between Receptors for IL-2 and IL-4
Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S., Arai, K.-I., & Sugamura, K. (1993) · Science · doi:10.1126/science.8266076 · Cited by 725
Interaction of IL-2Rβ and γ c Chains with Jak1 and Jak3: Implications for XSCID and XCID
Russell, S. M., Johnston, J. A., Noguchi, M., Kawamura, M., Bacon, C. M., Friedmann, M., Berg, M., McVicar, D. W., Witthuhn, B. A., Silvennoinen, O., et al. (1994) · Science · doi:10.1126/science.7973658 · Cited by 655
Insulators: many functions, many mechanisms
West, A. G., Gaszner, M., & Felsenfeld, G. (2002) · Genes & Development · doi:10.1101/gad.954702 · Cited by 631
Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-4 Receptor
Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E., et al. (1993) · Science · doi:10.1126/science.8266078 · Cited by 605
Antoine, C., Müller, S., Cant, A., Cavazzana-Calvo, M., Veys, P., Vossen, J., Fasth, A., Heilmann, C., Wulffraat, N., Seger, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12513-5 · Cited by 579
May, C., Rivella, S., Callegari, J., Heller, G., Gaensler, K. M. L., Luzzatto, L., & Sadelain, M. (2000) · Nature · doi:10.1038/35017565 · Cited by 567
Self-citationCutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex
Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D., & Sugamura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.1 · Cited by 541
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.
Yu, S. F., von Rüden, T., Kantoff, P. W., Garber, C., Seiberg, M., Rüther, U., Anderson, W. F., Wagner, E. F., & Gilboa, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3194 · Cited by 541
Buckley, R. H., Schiff, R. I., Schiff, S. E., Markert, M. L., Williams, L. W., Harville, T. O., Roberts, J. L., & Puck, J. M. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70199-9 · Cited by 540
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., & Moen, R. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.4.1125 · Cited by 532
Murine leukemia induced by retroviral gene marking
Li, Z., Düllmann, J., Schiedlmeier, B., Schmidt, M., von Kalle, C., Meyer, J., Forster, M., Stocking, C., Wahlers, A., Frank, O., et al. (2002) · Science · doi:10.1126/science.1068893 · Cited by 525
New genes involved in cancer identified by retroviral tagging
Suzuki, T., Shen, H., Akagi, K., Morse, H. C., Malley, J. D., Naiman, D. Q., Jenkins, N. A., & Copeland, N. G. (2002) · Nature Genetics · doi:10.1038/ng949 · Cited by 420
Morishita, K., Parker, D. S., Mucenski, M. L., Jenkins, N. A., Copeland, N. G., & Ihle, J. N. (1988) · Cell · doi:10.1016/s0092-8674(88)91175-0 · Cited by 404
AAV serotype 2 vectors preferentially integrate into active genes in mice
Nakai, H., Montini, E., Fuess, S., Storm, T. A., Grompe, M., & Kay, M. A. (2003) · Nature Genetics · doi:10.1038/ng1179 · Cited by 392
Cytokines and immunodeficiency diseases
Leonard, W. J. (2001) · Nature Reviews Immunology · doi:10.1038/35105066 · Cited by 390
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
Mikkers, H., Allen, J., Knipscheer, P., Romeyn, L., Hart, A., Vink, E., & Berns, A. (2002) · Nature Genetics · doi:10.1038/ng950 · Cited by 377
Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion
Corcoran, L. M., Adams, J. M., Dunn, A. R., & Cory, S. (1984) · Cell · doi:10.1016/0092-8674(84)90306-4 · Cited by 345
Functional Participation of the IL-2 Receptor γ Chain in IL-7 Receptor Complexes
Kondo, M., Takeshita, T., Higuchi, M., Nakamura, M., Sudo, T., Nishikawa, S.-L., & Sugamura, K. (1994) · Science · doi:10.1126/science.8128231 · Cited by 337
Baron, U. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2723 · Cited by 335
Royer‐Pokora, B., Loos, U., & Ludwig, W. D. (1991) · PubMed · Cited by 277
Rohdewohld, H., Weiher, H., Reik, W., Jaenisch, R., & Breindl, M. (1987) · Journal of Virology · doi:10.1128/jvi.61.2.336-343.1987 · Cited by 243
A chromatin insulator protects retrovirus vectors from chromosomal position effects
Emery, D. W., Yannaki, E., Tubb, J., & Stamatoyannopoulos, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160159597 · Cited by 242
Peripheral blood lymphocytes as target cells of retroviral vector- mediated gene transfer
Mavilio, F., Ferrari, G., Rossini, S., Nobili, N., Bonini, C., Casorati, G., Traversari, C., & Bordignon, C. (1994) · Blood · doi:10.1182/blood.v83.7.1988.1988 · Cited by 239
Bolotin, E., Annett, G., Parkman, R., & Weinberg, K. (1999) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701655 · Cited by 217
Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin
Vijaya, S., Steffen, D. L., & Robinson, H. L. (1986) · Journal of Virology · doi:10.1128/jvi.60.2.683-692.1986 · Cited by 208
Rivella, S., Callegari, J., May, C., Tan, C., & Sadelain, M. (2000) · Journal of Virology · doi:10.1128/.74.10.4679-4687.2000 · Cited by 201
Self-citationProviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas.
Selten, G., Cuypers, H. T., & Berns, A. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03852.x · Cited by 198
Osada, H., Grutz, G., Axelson, H., Forster, A., & Rabbitts, T. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9585 · Cited by 192
Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex
Kimura, Y., Takeshita, T., Kondo, M., Ishii, N., Nakamura, M., Van Snick, J., & Sugamura, K. (1995) · International Immunology · doi:10.1093/intimm/7.1.115 · Cited by 190
Safety of retroviral gene marking with a truncated NGF receptor
Bonini, C., Grez, M., Traversari, C., Ciceri, F., Marktel, S., Ferrari, G., Dinauer, M., Sadat, M., Aiuti, A., Deola, S., et al. (2003) · Nature Medicine · doi:10.1038/nm0403-367 · Cited by 177
O'Reilly, R. J., Small, T. N., Papadopoulos, E., Lucas, K., Lacerda, J., & Koulova, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00983.x · Cited by 175
Barata, J. T., Cardoso, A. A., Nadler, L. M., & Boussiotis, V. A. (2001) · Blood · doi:10.1182/blood.v98.5.1524 · Cited by 173
Second Child in French Trial Is Found to Have Leukemia
Marshall, E. (2003) · Science · doi:10.1126/science.299.5605.320 · Cited by 170
NATURALLY OCCURRING PRIMARY DEFICIENCIES OF THE IMMUNE SYSTEM
Fischer, A., Cavazzana-Calvo, M., Basile, G. D. S., DeVillartay, J. P., Di Santo, J. P., Hivroz, C., Rieux-Laucat, F., & Le Deist, F. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.93 · Cited by 163
Schmidt, M., Hoffmann, G., Wissler, M., Lemke, N., Müßig, A., Glimm, H., Williams, D. A., Ragg, S., Hesemann, C.-U., & von Kalle, C. (2001) · Human Gene Therapy · doi:10.1089/104303401750148649 · Cited by 162
Chromatin Insulators and Boundaries: Effects on Transcription and Nuclear Organization
Gerasimova, T. I., & Corces, V. G. (2001) · Annual Review of Genetics · doi:10.1146/annurev.genet.35.102401.090349 · Cited by 161
Leonard, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.229 · Cited by 160
Giri, J. G., Wells, J., Dower, S., McCall, C. E., Guzman, R. N., Slack, J. L., Bird, T. A., Shanebeck, K. D., Grabstein, K. H., Sims, J. E., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5802 · Cited by 148
Weichselbaum, R. R., & Kufe, D. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90013-1 · Cited by 146
RNA 3′ Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and Efficacy
Zaiss, A. K., Son, S., & Chang, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7209-7219.2002 · Cited by 137
Thymic lymphomas in interleukin 9 transgenic mice.
Renauld, J., van der Lugt, N. M. T., Vink, A., van ROON, M. A., Godfraind, C., Warnier, G., Merz, H., Feller, A. C., Berns, A. J. M., & SNICK, J. V. (1994) · PubMed · Cited by 134
Yeast Retrotransposons: Finding a Nice Quiet Neighborhood
Boeke, J. D., & Devine, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81450-6 · Cited by 134
Lazo, P. A., Lee, J. S., & Tsichlis, P. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.170 · Cited by 103
Larson, R. C., Osada, H., Ta, L., Lavenir, I., & Rabbitts, T. H. (1995) · PubMed · Cited by 94
Soudais, C., Tsujino, S., Sharara, L. I., Guy‐Grand, D., Taniguchi, T., Fischer, A., & Santo, J. P. D. (2000) · Blood · doi:10.1182/blood.v95.10.3071 · Cited by 88
Bartholomew, C., & Ihle, J. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1820-1828.1991 · Cited by 86
Overexpression of NPM–ALK induces different types of malignant lymphomas in IL-9 transgenic mice
de Lange, K., Uckert, W., Blankenstein, T. J. F., Nadrowitz, R., Bittner, C., Renauld, J., Snick, J. V., Feller, A. C., & Merz, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206076 · Cited by 74
Neale, G., Rehg, J., & Goorha, R. (1995) · Blood · doi:10.1182/blood.v86.8.3060.3060 · Cited by 74
Mouse models for multistep tumorigenesis.
Wu, X.-M., & Pandolfi, P. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02127-4 · Cited by 70
Gene Therapy Using Hematopoietic Stem Cells: Sisyphus Approaches the Crest
Halene, S., & Kohn, D. B. (2000) · Human Gene Therapy · doi:10.1089/10430340050032366 · Cited by 63
Self-citationHo, V., Pointer, R., Ceredig, R. H., & Dg, O. (1996) · PubMed · Cited by 63
A Review of Epstein-Barr Virus Infection in Patients with Immunodeficiency Disorders
Okano, M., & Gross, T. G. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40780-3 · Cited by 53
Fatal Leukemia in Interleukin-15 Transgenic Mice
Fehniger, T. A., Suzuki, K., VanDeusen, J. B., Cooper, M. A., Freud, A. G., & Caligiuri, M. A. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0379 · Cited by 49
Chromosomal translocation master genes, mouse models and experimental therapeutics
Rabbitts, T. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204597 · Cited by 48
Rabbitts, T. H., Bucher, K., Chung, G., Grütz, G., Warren, A. J., & Yamada, Y. (1999) · PubMed · Cited by 46
Strayer, D. S., Branco, F., Zern, M. Α., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0657 · Cited by 45
Gene therapy for genetic haematological disorders and immunodeficiencies
Kohn, D. B. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00803.x · Cited by 42
Self-citationTranscription Factors: Normal and Malignant Development of Blood Cells
Horiguchi‐Yamada, J. (2001) · International Journal of Hematology · doi:10.1007/bf02982077 · Cited by 41
Mouse models for multistep tumorigenesis
Wu, X., & Pandolfi, P. P. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82000-6 · Cited by 38
Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency
Heim, D. A., & Cynthia, C. E. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17802.x · Cited by 32
Targeting Retroviral Integration?
Bushman, F. D. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0724 · Cited by 28
Therapeutic globin gene delivery using lentiviral vectors.
Rivella, S. B., & Sadelain, M. (2002) · PubMed · Cited by 18
Self-citationÅsjö, B., Skoog, L. K., Hallén, I. P., Wiener, F., Isaak, D. D., Cerny, J., & Fenyö, E.-M. (1985) · PubMed · Cited by 13
Sturm und Drang over Suicidal Lymphocytes
Sadelain, M., & Rivière, I. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0619 · Cited by 13
Self-citationSadelain, M. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.266 · Cited by 11
Self-citationUse of Intron-Disrupted Polyadenylation Sites To Enhance Expression and Safety of Retroviral Vectors
Ismail, S. I., Rohll, J. B., Kingsman, S. M., Kingsman, A. J., & Uden, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.199-204.2001 · Cited by 5
Retroviral Vector Design for Cancer Gene Therapy
Baum, C., Ostertag, W., von Laer, D., & Stocking, C. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50002-1 · Cited by 5
Cited by
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,641
Long-term outcomes following CAR T cell therapy: what we know so far
Cappell, K. M., & Kochenderfer, J. N. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00754-1 · Cited by 1,382
Toxicity and management in CAR T-cell therapy
Bonifant, C. L., Jackson, H. J., Brentjens, R. J., & Curran, K. J. (2016) · Molecular Therapy - Oncolytics · doi:10.1038/mto.2016.11 · Cited by 885
Effects of Retroviruses on Host Genome Function
Jern, P., & Coffin, J. M. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.42.110807.091501 · Cited by 499
Noninvasive cell-tracking methods
Kircher, M. F., Gambhir, S. S., & Grimm, J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.141 · Cited by 501
Metadata
- Authors
- Kohn, D. B., Sadelain, M., & Glorioso, J. C.
- Venue
- Nature Reviews Cancer
- Published
- 2003-07-01
- Volume
- 3
- Issue
- 7
- Pages
- 477-488
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2011742128
- Cited by
- 344
- References
- 89
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.